B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gsk 690693

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gsk 690693, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ruboxistaurin
49 shared targets
enzastaurin
33 shared targets
ruxolitinib
41 shared targets
midostaurin
53 shared targets
pf
33 shared targets
lestaurtinib
75 shared targets
alvocidib
41 shared targets
tae
59 shared targets
r
54 shared targets
uprosertib
17 shared targets
Loading evidence profile...

This evidence profile for Gsk 690693 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.